Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Examining brain mechanisms of TMS in depression and anxiety

Official title: Neural Effects of Transcranial Magnetic Stimulation Using Concurrent Functional Magnetic Resonance Imaging

Run by University of Iowa · NCT06633913 · Data updated 2026-11-12

This study is testing how a brain treatment called TMS affects people with depression and anxiety by looking at their brain activity during and after the treatment.

More Depression trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment97 (estimated)
SponsorUniversity of Iowa
Academic / other
Drugs / interventionsradiation
Locations1 site (Iowa City, Iowa)
StatusRecruiting
StartedApril 19, 2024
Main results expectedMarch 1, 2028
Study endsJanuary 31, 2029
Registry record updatedMarch 12, 2026
Trial IDNCT06633913 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18-65 with major depressive disorder or generalized anxiety disorder, as well as healthy controls without psychiatric diagnoses.

Probably not a fit

Patients with epilepsy, seizure disorders, or those with non-MRI-compatible implanted devices will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the neural mechanisms of transcranial magnetic stimulation (TMS) using concurrent functional magnetic resonance imaging (fMRI) in both healthy individuals and patients experiencing high levels of depression and anxiety. Participants will undergo cognitive and emotional assessments, followed by brain scans to identify optimal TMS locations. The study aims to determine the relationship between the immediate effects of single-pulse TMS and the long-term effects of repetitive TMS, as well as how these effects correlate with symptoms of negative affect. Approximately half of the participants will be male and half female, aged 18-65.

Why it matters

Potential benefit: If successful, this study could enhance understanding of TMS effects, potentially leading to improved treatments for depression and anxiety.

How similar studies have gone: Other studies have shown promise in using TMS and fMRI to understand brain mechanisms, but this specific approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion for patients:

* Diagnosis of major depressive disorder
* Age greater than or equal to 18 years
* Age less than or equal to 65 years
* Able to understand and consent for research participation
* English-speaking

Inclusion for healthy controls:

* Report no lifetime psychiatric diagnosis and treatment
* scores on Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder Questionnaire (GAD-7) lower than 4
* Age greater than or equal to 18 years
* Age less than or equal to 65 years
* Able to understand and consent for research participation
* English-speaking

Exclusion for all subjects:

* Age less than 18 years
* Age greater than 65 years
* With epilepsy or seizure disorder
* With implanted ferromagnetic equipment in their face or skull near the stimulation target

MRI Exclusion criteria for all subjects:

* Implanted device including pacemaker, coronary stent, defibrillator, or neurostimulation device that is not MRI-compatible
* Metal in body including bullets, shrapnel, metal slivers
* Claustrophobia
* Uncontrolled high blood pressure
* Blood circulation problems
* Opiate medication, antihypertensive medication, or any medication that interferes with blood flow (interferes with fMRI recordings)
* Significant heart disease, such as atrial fibrillation
* Pregnancy in female participants
* Prior exposure to deep brain stimulation, rTMS, or tDCS (transcranial direct current stimulation) therapies
* History of neurological or cardiovascular disorders, brain surgery, radiation treatment, brain hemorrhage or tumor, stroke, or diabetes
* Significant traumatic brain injury (loss of consciousness, post-injury amnesia, significant radiological/neurological findings, penetrating brain injury)
* Refusal to abstain from illicit drug use for duration of the study
* Refusal to abstain from alcohol within 24 hours of scans

If you would like to participate in the study, click this link to fill out the Screening Form: https://redcap.icts.uiowa.edu/redcap/surveys/?s=DEYHWF8TMCHHW4Y7. Kindly note that our research team will contact you directly only if you meet the eligibility criteria for the study. Due to the high volume of responses, we are unable to reply to individual inquiries or provide feedback about eligibility decisions.

Where it's running

  • University of Iowa Carver College of Medicine
    Iowa City, Iowa, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.